Quick Answer
Compass Therapeutics, Inc. reported Shares Outstanding of 178.32 million shares for fiscal year 2025.
Compass Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 178.32M | +29.4% |
| 2024 | 137.82M | +8.0% |
| 2023 | 127.67M | +1.1% |
| 2022 | 126.30M | +25.3% |
| 2021 | 100.83M | +96.9% |
| 2020 | 51.22M | +924.4% |
| 2020 | 5.00M | -28.9% |
| 2019 | 7.03M | +40.7% |
| 2019 | 5.00M | +0.0% |
| 2018 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 177.57M | +29.1% | +28.4% |
| June 30, 2025 | 138.28M | +0.5% | +0.0% |
| March 31, 2025 | 138.28M | +0.5% | +0.3% |
| December 31, 2024 | 137.82M | +8.0% | +0.2% |
| September 30, 2024 | 137.59M | +8.0% | +0.0% |
| June 30, 2024 | 137.59M | +8.0% | +0.0% |
| March 31, 2024 | 137.59M | +8.9% | +7.8% |
| December 31, 2023 | 127.67M | +1.1% | +0.2% |
- Compass Therapeutics, Inc. showed an increase of +29.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Compass Therapeutics, Inc.’s shares outstanding has grown by 3466.5% (from 5.00 million shares to 178.32 million shares).
- The most recent figure is from Compass Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: